BioReliance is the leading provider of GLP and cGMP compliant contract services supporting testing, development and manufacturing of biologics worldwide. Founded in 1947 as Microbiological Associates, BioReliance has operations in the United States, United Kingdom and Germany.
Products and services:
BioReliance testing services include: characterization of cell banks, release testing of bulk and final product, viral and DNA clearance studies, analytical services, genetic, mammalian and molecular toxicology, biodistribution studies and comprehensive testing for laboratory animals including serology and PCR testing on rodent and simian species.
BioReliance offers contract manufacturing services for mammalian cell derived viral therapeutics and agents expressed in E.coli and yeast. A full range of services is offered from process development, scale-up and qualification, bulk drug production, aseptic filling and final drug packaging. Regulatory support services include the preparation of Chemistry Manufacturing and Controls (CMC) sections of regulatory filings.
Last Updated: 05-01-2007